Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Nuclear Medicine

  Free Subscription

Articles published in Brain

Retrieve available abstracts of 59 articles:
HTML format

Single Articles

    May 2024
  1. TETZLOFF KA, Martin PR, Duffy JR, Utianski RL, et al
    Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
    Brain. 2024;147:1696-1709.
    PubMed     Abstract available

  2. CROWLEY SJ, Kanel P, Roytman S, Bohnen NI, et al
    Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.
    Brain. 2024;147:1799-1808.
    PubMed     Abstract available

    April 2024
  3. WANG YT, Therriault J, Servaes S, Tissot C, et al
    Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
    Brain. 2024;147:1497-1510.
    PubMed     Abstract available

    March 2024
  4. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
    Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
    Brain. 2024;147:936-948.
    PubMed     Abstract available

    December 2023
  5. SCHUMACHER J, Kanel P, Dyrba M, Storch A, et al
    Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
    Brain. 2023;146:4964-4973.
    PubMed     Abstract available

    November 2023
  6. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    PubMed     Abstract available

    October 2023
  7. LAURENCIN C, Lancelot S, Brosse S, Merida I, et al
    Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
    Brain. 2023 Oct 3:awad338. doi: 10.1093.
    PubMed     Abstract available

    September 2023
  8. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    PubMed     Abstract available

  9. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    PubMed     Abstract available

    August 2023
  10. KOSHIMORI Y, Cusimano MD, Vieira EL, Rusjan PM, et al
    Astrogliosis marker 11C-SL2511.88 PET in traumatic brain injury with persistent symptoms.
    Brain. 2023 Aug 21:awad279. doi: 10.1093.
    PubMed     Abstract available

  11. WUESTEFELD A, Pichet Binette A, Berron D, Spotorno N, et al
    Age-related and amyloid-beta-independent tau deposition and its downstream effects.
    Brain. 2023;146:3192-3205.
    PubMed     Abstract available

    July 2023
  12. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    PubMed     Abstract available

    June 2023
  13. THERRIAULT J, Grothe MJ
    Towards in vivo PET imaging of primary age-related tauopathy.
    Brain. 2023 Jun 16:awad210. doi: 10.1093.

  14. SCHOONHOVEN DN, Coomans EM, Millan AP, van Nifterick AM, et al
    Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study.
    Brain. 2023 Jun 5:awad189. doi: 10.1093.
    PubMed     Abstract available

    April 2023
  15. NAM MH, Ko HY, Kim D, Lee S, et al
    Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
    Brain. 2023 Apr 17:awad037. doi: 10.1093.
    PubMed     Abstract available

    February 2023
  16. JACK CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, et al
    Predicting amyloid PET and tau PET stages with plasma biomarkers.
    Brain. 2023 Feb 15:awad042. doi: 10.1093.
    PubMed     Abstract available

  17. FLORIAN H, Wang D, Arnold SE, Boada M, et al
    Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
    Brain. 2023 Feb 2:awad024. doi: 10.1093.
    PubMed     Abstract available

    January 2023
  18. MENG Y, Goubran M, Rabin JS, McSweeney M, et al
    Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Jan 25:awac459. doi: 10.1093.
    PubMed     Abstract available

  19. VAN ARENDONK J, Neitzel J, Steketee RME, van Assema DME, et al
    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
    Brain. 2023;146:337-348.
    PubMed     Abstract available

  20. KATSUMI Y, Putcha D, Eckbo R, Wong B, et al
    Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy.
    Brain. 2023;146:295-306.
    PubMed     Abstract available

    December 2022
  21. PERANI D
    The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course.
    Brain. 2022;145:4157-4159.

  22. YOO HS, Jeong SH, Oh KT, Lee S, et al
    Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
    Brain. 2022;145:4448-4458.
    PubMed     Abstract available

    November 2022
  23. TSAGKARIS S, Yau EKC, McClelland V, Papandreou A, et al
    Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia.
    Brain. 2022 Nov 29:awac439. doi: 10.1093.
    PubMed     Abstract available

  24. VAN DER WEIJDEN CWJ, Biondetti E, Gutmann IW, Dijkstra H, et al
    Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status.
    Brain. 2022 Nov 21:awac436. doi: 10.1093.
    PubMed     Abstract available

  25. BETTHAUSER TJ, Bilgel M, Koscik RL, Jedynak BM, et al
    Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.
    Brain. 2022;145:4065-4079.
    PubMed     Abstract available

    September 2022
  26. SPOTORNO N, Strandberg O, Vis G, Stomrud E, et al
    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Brain. 2022 Sep 21. pii: 6710203. doi: 10.1093.
    PubMed     Abstract available

  27. GROOT C, Smith R, Stomrud E, Binette AP, et al
    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
    Brain. 2022 Sep 9. pii: 6695020. doi: 10.1093.
    PubMed     Abstract available

    August 2022
  28. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
    Tau positron emission tomography in preclinical Alzheimer's disease.
    Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
    PubMed     Abstract available

  29. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    PubMed     Abstract available

    July 2022
  30. LONG JM, Coble DW, Xiong C, Schindler SE, et al
    Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
    Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
    PubMed     Abstract available

    June 2022
  31. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    PubMed     Abstract available

    April 2022
  32. ALSHELH Z, Brusaferri L, Saha A, Morrissey E, et al
    Neuroimmune signatures in chronic low back pain subtypes.
    Brain. 2022;145:1098-1110.
    PubMed     Abstract available

    February 2022
  33. ANG YS, Cusin C, Petibon Y, Dillon DG, et al
    A multi-pronged investigation of option generation using depression, PET and modafinil.
    Brain. 2022 Feb 12. pii: 6527662. doi: 10.1093.
    PubMed     Abstract available

    January 2022
  34. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    PubMed     Abstract available

  35. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
    Genetically identical twins show comparable tau PET load and spatial distribution.
    Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
    PubMed     Abstract available

    December 2021
  36. REINARTZ M, Gabel S, Schaeverbeke J, Meersmans K, et al
    Changes in the language system as amyloid-beta accumulates.
    Brain. 2021;144:3756-3768.
    PubMed     Abstract available

  37. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    PubMed     Abstract available

  38. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    PubMed     Abstract available

  39. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    PubMed     Abstract available

  40. HERMANIDES J, Hong YT, Trivedi M, Outtrim J, et al
    Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury.
    Brain. 2021;144:3492-3504.
    PubMed     Abstract available

    November 2021
  41. YAN S, Zheng C, Paranjpe MD, Li Y, et al
    Sex modifies APOE epsilon4 dose effect on brain tau deposition in cognitively impaired individuals.
    Brain. 2021;144:3201-3211.
    PubMed     Abstract available

    October 2021
  42. DOPPLER CEJ, Kinnerup MB, Brune C, Farrher E, et al
    Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Brain. 2021;144:2732-2744.
    PubMed     Abstract available

  43. BERRON D, Vogel JW, Insel PS, Pereira JB, et al
    Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.
    Brain. 2021;144:2771-2783.
    PubMed     Abstract available

  44. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    PubMed     Abstract available

  45. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    PubMed     Abstract available

    August 2021
  46. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    PubMed     Abstract available

  47. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed     Abstract available

    July 2021
  48. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed     Abstract available

    June 2021
  49. WALSH J, Tozer DJ, Sari H, Hong YT, et al
    Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Brain. 2021;144:1361-1371.
    PubMed     Abstract available

  50. ZHOU L, Li G, Zhang Y, Zhang M, et al
    Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Brain. 2021;144:1488-1497.
    PubMed     Abstract available

  51. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    PubMed     Abstract available

    May 2021
  52. HOSP JA, Dressing A, Blazhenets G, Bormann T, et al
    Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.
    Brain. 2021;144:1263-1276.
    PubMed     Abstract available

    April 2021
  53. MAZERE J, Dilharreguy B, Catheline G, Vidailhet M, et al
    Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia.
    Brain. 2021;144:909-923.
    PubMed     Abstract available

  54. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.

  55. PASCUAL B, Funk Q, Zanotti-Fregonara P, Cykowski MD, et al
    Neuroinflammation is highest in areas of disease progression in semantic dementia.
    Brain. 2021 Apr 6. pii: 6213358. doi: 10.1093.
    PubMed     Abstract available

    March 2021
  56. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    PubMed     Abstract available

    February 2021
  57. ARNALDI D, Chincarini A, Hu MT, Sonka K, et al
    Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Brain. 2021;144:278-287.
    PubMed     Abstract available

    December 2020
  58. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    PubMed     Abstract available

    November 2020
  59. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.